agilon health, inc.
NYSE:AGL
2.7 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 4,316.363 | 2,708.211 | 1,833.559 | 1,218.333 | 794.411 |
| Cost of Revenue
| 4,262.736 | 2,595.925 | 1,757.146 | 1,124.183 | 765.9 |
| Gross Profit
| 53.627 | 112.286 | 76.413 | 94.15 | 28.511 |
| Gross Profit Ratio
| 0.012 | 0.041 | 0.042 | 0.077 | 0.036 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 285.76 | 218.945 | 455.821 | 137.292 | 122.832 |
| Selling & Marketing Expenses
| -0.188 | 0 | 0 | 0 | 0 |
| SG&A
| 285.572 | 218.945 | 455.821 | 137.292 | 122.832 |
| Other Expenses
| 27.84 | 24.725 | 14.544 | 13.531 | 12.253 |
| Operating Expenses
| 285.572 | 218.945 | 470.365 | 150.823 | 135.085 |
| Operating Income
| -231.945 | -110.214 | -393.952 | -56.673 | -106.574 |
| Operating Income Ratio
| -0.054 | -0.041 | -0.215 | -0.047 | -0.134 |
| Total Other Income Expenses Net
| 37.483 | 4.525 | -10.646 | -5.67 | -8.113 |
| Income Before Tax
| -194.462 | -105.689 | -404.598 | -62.343 | -114.687 |
| Income Before Tax Ratio
| -0.045 | -0.039 | -0.221 | -0.051 | -0.144 |
| Income Tax Expense
| 0.791 | 1.175 | 0.886 | 0.865 | -0.232 |
| Net Income
| -215.048 | -106.864 | -405.484 | -63.208 | -114.455 |
| Net Income Ratio
| -0.05 | -0.039 | -0.221 | -0.052 | -0.144 |
| EPS
| -0.53 | -0.26 | -1.01 | -0.16 | -0.29 |
| EPS Diluted
| -0.53 | -0.26 | -1.01 | -0.16 | -0.29 |
| EBITDA
| -211.784 | -96.442 | -383.782 | -40.109 | -64.206 |
| EBITDA Ratio
| -0.049 | -0.036 | -0.209 | -0.033 | -0.081 |